| For: | Niu ZS, Li BK, Wang M. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World J Gastroenterol 2002; 8(5): 822-826 [PMID: 12378623 DOI: 10.3748/wjg.v8.i5.822] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i5/822.htm |
| Number | Citing Articles |
| 1 |
Valentina Masciale, Federico Banchelli, Giulia Grisendi, Anna Valeria Samarelli, Giulia Raineri, Tania Rossi, Michele Zanoni, Michela Cortesi, Sara Bandini, Paola Ulivi, Giovanni Martinelli, Franco Stella, Massimo Dominici, Beatrice Aramini. The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations. Journal of Biological Chemistry 2024; 300(12) doi: 10.1016/j.jbc.2024.107994
|
| 2 |
AM Attallah, M El-Far, MA Abdelrazek, MM Omran, AA Attallah, AA Elkhouly, HM Elkenawy, K Farid. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. British Journal of Biomedical Science 2017; 74(4) doi: 10.1080/09674845.2017.1334739
|
| 3 |
Ramdzan M. Zubaidah, Gek San Tan, Sandra B. E. Tan, Seng Gee Lim, Qingsong Lin, Maxey C. M. Chung. 2‐D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. PROTEOMICS 2008; 8(23-24) doi: 10.1002/pmic.200800322
|
| 4 |
Filiz Türe Özdemir, Arzu Tiftikci, Seda Sancak, Fatih Eren, Veysel Tahan, Hakan Akın, Feyza Gündüz, Ala Eldeen Kedrah, Yücel Üstündağ, Erol Avşar, Nurdan Tözün, Osman Özdoğan. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey. Journal of Gastrointestinal Cancer 2010; 41(3) doi: 10.1007/s12029-010-9140-5
|
| 5 |
Long Yu, Jian Huang, Xi-Ran Zhang, Li-Jie Ma, Yan Sun, Dong-Dong Lu, Lu-Hong Sun, Xing-Hua Huang. Codon 249 mutation in exon 7 of <italic>p53</italic> gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World Journal of Gastroenterology 2003; 9(4): 692-695 doi: 10.3748/wjg.v9.i4.692
|
| 6 |
Carlos Eduardo Andrade Chagas, Bruna Kempfer Bassoli, Camila Alexandre Soares de Souza, Rafael Deminice, Alceu Afonso Jordão Júnior, Sérgio Alberto Rupp Paiva, Maria Lúcia Zaidan Dagli, Thomas Prates Ong, Fernando Salvador Moreno. Folic acid supplementation during early hepatocarcinogenesis: Cellular and molecular effects. International Journal of Cancer 2011; 129(9) doi: 10.1002/ijc.25886
|
| 7 |
R. Heidor, J. M. Affonso, T. P. Ong, F. S. Moreno. Nutrition and Cancer Prevention. 2019; doi: 10.1039/9781788016506-00339
|
| 8 |
Jun Cui, Bao-Wei Dong, Ping Liang, Xiao-Ling Yu, De-Jiang Yu. Effect of c-<italic>myc</italic>, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection. World Journal of Gastroenterology 2004; 10(10): 1533-1536 doi: 10.3748/wjg.v10.i10.1533
|
| 9 |
Bin-Wen Wu, Yuan Wu, Jia-Long Wang, Ju-Sheng Lin, Shu-Yu Yuan, Ai Li, Wu-Ren Cui. Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells. World Journal of Gastroenterology 2003; 9(2): 271-275 doi: 10.3748/wjg.v9.i2.271
|
| 10 |
Peng Dai, Liping Wang. Targeting c-MYC has a key role in hepatocellular carcinoma therapy. Critical Reviews in Oncology/Hematology 2025; 213 doi: 10.1016/j.critrevonc.2025.104786
|
| 11 |
Lisheng Ge, Ziqiu Wang, Meifang Wang, Siddhartha Kar, Brian I. Carr. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog. Journal of Hepatology 2004; 41(5) doi: 10.1016/j.jhep.2004.07.021
|
| 12 |
Xin-Juan Kong, Yu-Hu Song, Ju-Sheng Lin, Huan-Jun Huang, Nan-Xia Wang, Nan-Zhi Liu, Bin Li, You-Xin Jin. Maxizyme-mediated specific inhibition on mutant-type p53 <italic>in vitro</italic>. World Journal of Gastroenterology 2003; 9(7): 1571-1575 doi: 10.3748/wjg.v9.i7.1571
|
| 13 |
Ming-Yi Li, Hua Deng, Jia-Ming Zhao, Dong Dai, Xiao-Yu Tan. PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World Journal of Gastroenterology 2003; 9(6): 1220-1226 doi: 10.3748/wjg.v9.i6.1220
|
| 14 |
Ming-Yi Li, Hua Deng, Jia-Ming Zhao, Dong Dai, Xiao-Yu Tan. Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World Journal of Gastroenterology 2003; 9(8): 1683-1688 doi: 10.3748/wjg.v9.i8.1683
|
| 15 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
| 16 |
Su-Xia Liu, Wen-Sheng Sun, Ying-Lin Cao, Chun-Hong Ma, Li-Hui Han, Li-Ning Zhang, Zhen-Guang Wang, Fa-Liang Zhu. Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World Journal of Gastroenterology 2004; 10(3): 366-370 doi: 10.3748/wjg.v10.i3.366
|